PhD student

Jibin obtained Master degree of Pharmaceutical Engineering from Wuhan University, studying the biological function of immune checkpoint inhibitor blocking PD-1/PD-L1 pathway, and had two-year work experience in developing monoclonal antibodies for cancer immunotherapy. Jibin is intrigued by the mechanism of co-stimulatory/inhibitory signaling. He plans to pursue my Ph.D. degree in Immunology in the future.